首页> The European respiratory journal> Concomitant medications and clinical outcomes in idiopathic pulmonary fibrosis.

Concomitant medications and clinical outcomes in idiopathic pulmonary fibrosis.

导出 OA

翻译打印收藏纠错

第一作者： Michael,Kreuter

第一单位： Center for Interstitial and Rare Lung Diseases, Pneumonology, Thoraxklinik, University of Heidelberg, Member of the German Center for Lung Research, Heidelberg, Germany michael.kreuter@med.uni-heidelberg.de.

作者： Michael,Kreuter ^[1] ; David J,Lederer ^[2] ; Vincent,Cottin ^[3] ; Nicolas,Kahn ^[4] ; Brett,Ley ^[5] ; Carlo,Vancheri ^[6] ; Derek,Weycker ^[7] ; Mark,Atwood ^[7] ; Klaus-Uwe,Kirchgaessler ^[8] ; Christopher J,Ryerson ^[9]

作者单位： Center for Interstitial and Rare Lung Diseases, Pneumonology, Thoraxklinik, University of Heidelberg, Member of the German Center for Lung Research, Heidelberg, Germany michael.kreuter@med.uni-heidelberg.de. ^[1] Depts of Medicine and Epidemiology, Columbia University Irving Medical Center, New York, NY, USA. ^[2] Dept of Respiratory Medicine, Reference Center for Rare Pulmonary Diseases, Louis Pradel Hospital, Claude Bernard University Lyon 1, UMR754, Lyon, France. ^[3] Center for Interstitial and Rare Lung Diseases, Pneumonology, Thoraxklinik, University of Heidelberg, Member of the German Center for Lung Research, Heidelberg, Germany. ^[4] Dept of Medicine, University of California, San Francisco, San Francisco, CA, USA. ^[5] Dept of Clinical and Experimental Medicine, University of Catania, Catania, Italy. ^[6] Policy Analysis Inc. (PAI), Brookline, MA, USA. ^[7] F. Hoffmann-La Roche Ltd, Basel, Switzerland. ^[8] Dept of Medicine, University of British Columbia, Vancouver, BC, Canada. ^[9]

医学主题词共病现象(Comorbidity);药物相互作用(Drug Interactions);药物疗法, 联合(Drug Therapy, Combination);人类(Humans);特发性肺纤维化(Idiopathic Pulmonary Fibrosis);随机对照试验(主题)(Randomized Controlled Trials as Topic)

DOI 10.1183/13993003.01188-2019

PMID 31537696

发布时间 2020-10-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交